CLINICAL SIGNIFICANCE OF DETERMINATION OF LIPOCALIN-2 ASSOCIATED WITH NEUTROPHILIC GELATINASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE (LITERATURE REVIEW)
https://doi.org/10.24884/1561-6274-2018-22-4-50-56
Abstract
Improvement of diagnosis and prediction methods of the chronic kidney disease is associated with the identification and studying of new biomarkers, not depending on kidney filtration function. In this literature review we present the research data of Lipocalin-2 associated with neutrophilic gelatinase in diagnostics, assessment of severity and rate of progression of chronic kidney disease both in adults and children.
About the Authors
A. V. Eremeeva
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
8/2 Trubetskaya St., Moscow, Russia, 119991
Eremeeva Alina Vladimirovna, MD, PhD Associate prof. of the Chair of Pediatrics and Children’s Infectious Diseases Tel.: +7-916-670-14-87
V. V. Dlin
Yu.E. Veltishchev Scientific Research Clinical Institute of Pediatrics, N.I. Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
2 Taldomskaya St., Moscow, Russia, 125412
Professor Dlin Vladimir Viktorovich, MD, PhD, DMedSci
Deputy Director for Science Tel.: +7-916-634-34-53
A. A. Korsunsky
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
8/2 Trubetskaya St., Moscow, Russia, 119991
Professor Korsunsky Anatoly Alexandrovich, MD, PhD, DMedSci
Head of the Chair of Pediatrics and Children’s Infectious Diseases Tel.: +7-495-256-21-62
N. M. Zaikova
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
8/2 Trubetskaya St., Moscow, Russia, 119991
Zaikova Natalia Mikhailovna, MD, PhD Assistant of the Chair of Pediatrics and Children’s Infectious Diseases, Tel: +7-964-529-90-49
E. D. Bondarenko
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
8/2 Trubetskaya St., Moscow, Russia, 119991
Bondarenko Elena Dmitrievna, MD, PhD Assistant of the Chair of Pediatrics and Children’s Infectious Diseases Tel.: +7-916-098-75-63
References
1. Kjeldsen L, Okamoto K, Arito M et al. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994;83:799–807
2. Chu ST, Lin HJ, Huang HL, Chen YH. The hydrophobic pocket of 24p3 protein from mouse uterine luminal fluid: fatty acid and retinol binding activity and predicted structural similarity to lipocalins. J Pept Res 1998;52:390–397
3. Bao G, Clifton M, Hoette TM et al. Iron traffics in circulation bound to a siderocalin (Ngal)- catechol complex. Nat Chem Biol 2010;6:602–609
4. Xuang HL, Chu ST, Chen YH. Ovarian steroids regulate 24p3 expression in mouse uterus during the natural estrous cycle and the preimplantation period. J Endocrinol 1999;162:11–19
5. Borregaard N, Cowland JB. Neutrophil gelatinase-associated lipocalin, a siderophore- binding eukaryotic protein. Biometals 2006;19:211–215
6. Aigner F, Maier HT, Schwelberger HG et al. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am J Transplant 2007; 7:779–788
7. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinaseassociated lipocalin from humans. Genomics 1997; 45:17–23
8. Owen HC, Roberts SJ, Ahmed SF, Farquharson C. Dexamethasone-induced expression of the glucocorticoid response gene lipocalin 2 in chondrocytes. Am J Physiol Endocrinol Metabol 2008; 294:1023–1034
9. Yan QW, Yang Q, Mody N et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 2007; 56:2533–2540
10. Devireddy LR, Teodoro JG, Richard FA, Green MR. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 2001; 293:829–834
11. Yang J, Goetz D, Li JY et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002;10:1045–1056
12. Gómez R, Conde J, Scotece M et al. What’s new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 2011;7:528–536
13. Flo TH, Smith KD, Sato S et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004;432:917–921
14. Devireddy LR, Hart DO, Goetz DH, Green MR. A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell 2010;141:1006–1017
15. Nairz M, Haschka D, Demetz E et al. Iron at the interface of immunity and infection. Front Pharmacol 5: 2014:152
16. Srinivasan G, Aitken JD, Zhang B et al. Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxininduced sepsis. J Immunol 2012; 189:1911–1919
17. Zhao H, Konishi A, Fujita Y et al. Lipocalin 2 bolsters innate and adaptive immune responses to blood-stage malaria infection by reinforcing host iron metabolism. Cell Host Microbe 2012;12:705–716
18. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14 (2003), pp. 2534-2543
19. Dent CL, Ma Q, Dastrala S et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 11 (2007), p. R127
20. Malyszko J, Bachorzewska-Gajewska H, Sitniewska E et al. Serum neutrophil gelatinase- associated lipocalin as a marker of renal function in non-diabetic patients with stage 2–4 chronic kidney disease. Ren Fail 30 (2008), pp. 625-628
21. Ko GJ, Grigoryev DN, Linfert D et al. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI to CKD transition. Am J Physiol Renal Physiol 298 (2010), pp. F1472-F1483
22. Aghel A, Shrestha K, Mullens W et al. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail 16 (2010), pp. 49-54
23. Viau A, El Karoui K, Laouari D et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest 120 (2010), pp. 4065-4076
24. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens 2008; 17: 127–132
25. Meldrum KK, Hile K, Meldrum DR et al. Simulated ischemia induced renal tubular cell apoptosis through a nuclear factor-κB dependent mechanism. J Urol 2002; 168: 248–252
26. Mishra J, Mori K, Ma Q et al. Neutrophil gelatinaseassociated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004; 24: 307-315
27. Flo TH, Smith KD, Sato S et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004; 432: 917–921
28. Mitsnefes M, Kathman T, Mishra J et al. Serum NGAL as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007; 22: 101-108
29. Bolignano D, Coppolino G, Campo S et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transpl 2008; 23: 414-416
30. Kwon O, Phillips CL, Molitoris BA. Ischemia induces alterations in actin filaments in renal vascular smooth muscle cells. Am J Physiology Renal Physiology 2002. Vol. 282: 1012–1019
31. Kraydaschenko OV, Abramov AV, Dolinnaya MA. Role of biomarkers in estimation of renal tubulointerstitial tissue damage in patients with chronic glomerulonephritis. Lik Sprava 2015; (3- 4): 61-65
32. Bolignano D, Lacquaniti A, Coppolino G et al. Neutrophil gelatinaseassociated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res 2008; 31: 255–258
33. Bolignano D, Coppolino G, Lacquaniti A et al. Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function. Kidney Blood Press Res 2008; 31(4):274-279
34. Munna LP, Rekha S, Ravi M et al. Prognostic significance of urinary NGAL in chronic kidney disease. International Journal of Nephrology and Renovascular Disease 2015; 8; 139- 144
35. Вознесенская ТС, Бершова ТВ, Сергеева ТВ. Липокалин как маркер хронической болезни почек у детей со стероидрезистентным нефротическим синдромом. Российский педиатрический журнал 2013; 5: 20-25 [Voznesenskaya TS, Bershova TV, Sergeeva TV. Lipocalin as a marker of chronic kidney disease in children with steroid- resistant nephrotic syndrome. Rossijskij pediatricheskij zhurnal 2013; 5: 20-25]
36. Миронова СА, Звартау НЭ, Конради АО. Поражение почек при артериальной гипертензии: можем ли мы доверять старым маркерам? Артериальная гипертензия 2016; 22 (6): 536-550 [Mironova SA, Zvartau NEH, Konradi AO. Kidney damage in hypertension: can we trust old markers? Arterial’naya gipertenziya 2016; 22 (6): 536-550]
37. Kamijo-Ikemori A, Sugaya T, Kimura K et al. Urinary fatty acid binding protein in renal disease. Clin Chim Acta 2006; 374 (1-2): 1-7
38. Satoh-Asahara N, Suganami T, Majima T et al. Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome. Clin J Am Soc Nephrol 2011; 6 (2): 265-273
39. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS et al. Serum neutrophil gelatinase- associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Nephrology (Carlton) 2008; 13(2): 153-156
40. Blumczynski A, Soltysiak J, Lipkowska K et al. Hypertensive nephropathy in children – do we diagnose early enough? Blood Press 2012; 21 (4): 233-239
41. Aksan G, Inci S, Nar G et al. Serum neutrophil gelatinaseassociated lipocalin levels in patients with non-dipper hypertension. Clin Invest Med 2015; 38 (2): E53-62
42. Bolignano D, Lacquaniti A, Coppolino G et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 2009; 32(2):91-98
43. Yang YH, He XJ, Chen SR et al. Changes of serum and urine neutrophil gelatinase- associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study. Endocrine 2009;36(1):45-51
44. Kim SS, Song SH, Kim IJ et al. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients. Diabetes Metab Res Rev 2014 Nov;30(8):736-741
45. Pitashny M, Schwartz N, Qing X et al. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum 2007; 56(6):1894-903
46. Suzuki M, Wiers KM, Klein-Gitelman MS et al. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol 2008; 23: 403–412
47. Hinze CH, Suzuki M, Klein-Gitelman M et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum 2009; 60(9):2772-2781
Review
For citations:
Eremeeva A.V., Dlin V.V., Korsunsky A.A., Zaikova N.M., Bondarenko E.D. CLINICAL SIGNIFICANCE OF DETERMINATION OF LIPOCALIN-2 ASSOCIATED WITH NEUTROPHILIC GELATINASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE (LITERATURE REVIEW). Nephrology (Saint-Petersburg). 2018;22(4):50-56. (In Russ.) https://doi.org/10.24884/1561-6274-2018-22-4-50-56
Views:
3286
Email this article 